ALSERES PHARMACEUTICALS INC /DE (ALSE) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 18 transactions totaling $2.0M, demonstrating a bullish sentiment with $2.0M in net insider flow. The most recent transaction on Dec 27, 2011 involved a transaction of 2,331,034 shares valued at $0.
No significant insider buying has been recorded for ALSE in the recent period.
No significant insider selling has been recorded for ALSE in the recent period.
Based on recent SEC filings, insider sentiment for ALSE is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ALSERES PHARMACEUTICALS INC /DE (ALSE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading ALSE stock, having executed 18 transactions in the past 90 days. The most active insider is Robert L. Gipson (Executive), who has made 10 transactions totaling $17.8M.
Get notified when executives and directors at ALSE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 27, 2011 | L. Gipson Robert | Executive | Disposition | 2,331,034 | $N/A | $0 | |
| Dec 27, 2011 | Livingston Gipson Thomas | Executive | Disposition | 537,931 | $N/A | $0 | |
| Dec 27, 2011 | L. Gipson Robert | Executive | Disposition | 2,331,034 | $N/A | $0 | |
| Dec 22, 2011 | Livingston Gipson Thomas | Executive | Option Exercise | 537,931 | $2.50 | $1.3M | Large |
| Dec 22, 2011 | L. Gipson Robert | Executive | Option Exercise | 2,331,034 | $2.50 | $5.8M | Large |
| Dec 16, 2011 | L. Gipson Robert | Executive | Disposition | 60,000 | $N/A | $0 | |
| Dec 16, 2011 | Livingston Gipson Thomas | Executive | Disposition | 530,000 | $N/A | $0 | |
| Jun 1, 2011 | L. Gipson Robert | Executive | Conversion | 4,600,000 | $N/A | $0 | |
| Dec 31, 2010 | L. Gipson Robert | Executive | Disposition | 270,000 | $0.03 | $8.1K | |
| Jan 9, 2009 | L. Gipson Robert | Executive | Purchase | 1,456,522 | $0.69 | $1.0M | Large |
| Nov 20, 2008 | L. Gipson Robert | Executive | Purchase | 543,478 | $1.84 | $1000.0K | Large |
| Jan 2, 2008 | G. Savas Peter | Executive | Award | 11,212 | $N/A | $0 | |
| Jan 2, 2008 | L. Rice Kenneth Jr | Executive | Award | 4,485 | $N/A | $0 | |
| Jan 2, 2008 | Jerome Pykett Mark | Executive | Award | 6,777 | $N/A | $0 | |
| Jan 2, 2008 | Bobe Frank | Executive | Award | 3,363 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 4 | $15.0M | 62.0% |
Exercise(M) | 2 | $7.2M | 29.7% |
Purchase(P) | 2 | $2.0M | 8.3% |
Disposition(D) | 6 | $8.1K | 0.0% |
Award(A) | 4 | $0 | 0.0% |
Insiders at ALSERES PHARMACEUTICALS INC /DE are accumulating shares at an accelerated pace. With 6 insiders making 18 transactions totaling $2.0M in purchases versus $0 in sales, the net buying activity of $2.0M signals strong executive confidence. Robert L. Gipson (Executive) leads the buying activity with $17.8M in transactions across all time.